Newsroom

HOUSTON--(BUSINESS WIRE)--Das globale Energietechnologieunternehmen SLB (NYSE: SLB) gab heute eine erweiterte Zusammenarbeit mit Vår Energi bekannt, um die Bohrlochplanung und die integrierte Feldentwicklungsplanung in allen seinen Aktivitäten auf dem norwegischen Festlandsockel zu skalieren. Da die kollaborative Bohrlochplanung die Zykluszeiten bereits von Monaten auf Tage verkürzt und die integrierte Feldentwicklungsplanung voraussichtlich ähnliche Vorteile mit sich bringen wird, soll der erw...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On May 26, 2026, Verra Mobility announced that it received a termination notice from Avis...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Claritev Corporation (“Claritev” or the “Company”) (NYSE:CTEV) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On May 14, 2026, The Capitol Forum reported that the U.S. Department of Justice’s anti-trust division has launched a c...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Calix, Inc.  (“Calix” or the “Company”) (Calix, Inc.) securities during the period of January 28, 2026 through April 21, 2026, inclusive (“the Class Period”). If you suffered a loss on your Calix investments, you have until July 27, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after thi...

SAN FRANCISCO--(BUSINESS WIRE)--Rubedo Life Sciences, Inc. (Rubedo), ein KI-gestütztes Biotech-Unternehmen im klinischen Stadium, das sich auf selektive Medikamente zur Zellverjüngung mit Fokus auf alternde Zellen konzentriert, gab heute vorläufige Ergebnisse einer Phase-1b/2a-Studie mit RLS-1496 bei Patienten mit aktinischer Keratose (AK) bekannt, einer häufigen altersbedingten Erkrankung, die zu präkanzerösen Hautläsionen führt und am häufigsten nach dem 65. Lebensjahr auftritt.1 Die in den V...

NEW YORK & SAN FRANCISCO & SUZHOU, China--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Innovent Biologics, Inc. (01801.HK), today announced the companies have entered into a strategic global licensing and collaboration agreement for the research and development of 12 promising new breakthrough early-stage and de novo cancer medicines. The partnership includes licensing, co-development, and co-commercialization opportunities across a diverse portfolio of antibody-drug conjugates (ADCs) with nove...

HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. ("Oasis") is the manager to funds that beneficially own shares of Exeo Group, Inc. (1951 JT) ("Exeo" or the "Company"). Oasis has adopted the Japan FSA's "Principles of Responsible Institutional Investors" (a.k.a. the Japan Stewardship Code) and, in line with those principles, Oasis monitors and engages with its investee companies. Exeo’s share price performance has significantly lagged behind peers. Compared to January 2021, Exeo’s shar...

香港--(BUSINESS WIRE)--（ビジネスワイヤ） -- オアシス・マネジメント・カンパニー・リミテッド（以下「オアシス」または「弊社」）は、エクシオグループ株式会社（以下「エクシオ」または「同社」）（証券コード：1951）の株式を保有するファンドの運用会社です。オアシスは「責任ある機関投資家」の諸原則《日本版スチュワードシップ・コード》を遵守しており、この原則に沿ってオアシスは投資先企業のモニタリングとエンゲージメントを行っております。 エクシオの株価パフォーマンスは成長分野に強みを持つ同業他社と比較して大幅に劣後しています。2021年1月を起点とした株価変動率では、関電工（+662%）、高砂熱学（+477%）、きんでん（+387%）、大気社（+159%）が大幅に上昇する中、エクシオは+99%にとどまっています。 オアシスは、エクシオの真の価値を顕在化させるために、エクシオの長期保有株主として、継続的な対話を通じて同社の成長の促進、及びコーポレートガバナンスの改善に取り組んできました。これまで、IRおよびトップマネジメントとの面談や書簡を通じて、成長事業への注力と取締役会...

SAN FRANCISCO--(BUSINESS WIRE)--A Rubedo Life Sciences, Inc. (Rubedo), uma empresa de biotecnologia em estágio clínico, impulsionada por inteligência artificial e focada em medicamentos seletivos de rejuvenescimento celular direcionados a células envelhecidas, anunciou hoje os resultados preliminares de um estudo de Fase 1b/2a do RLS-1496 em pacientes com queratose actínica (QA), uma condição comum relacionada à idade que resulta em lesões cutâneas pré-cancerígenas, mais comumente observada apó...

LADERA RANCH, Calif.--(BUSINESS WIRE)--Strategic Storage Trust VI, Inc. (“SST VI” or the “Company”), a publicly registered non-listed real estate investment trust sponsored by an affiliate of SmartStop Self Storage REIT, Inc. (“SmartStop”) (NYSE: SMA), in partnership with SmartCentres (TSX: SRU.UN), is pleased to announce the opening of its second self-storage facility in the Greater Montréal Area. Located at 5500 Rue Notre-Dame Ouest in Montréal, Québec, the facility occupies a highly visible...